Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team ...

STORY: Benire Furahini Buchaguzi is at the forefront of Democratic Republic of Congo's uphill battle against mpox.The 22-year ...

The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 ...

The spread of mpox in congested refugee camps and prisons is raising vaccine needs as Africa struggles to contain multiple ...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated ...

The NIH clinical trial aims to address the knowledge gap regarding vaccine use in adolescent populations. A clinical trial ...

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated ...

Interim results of a phase 2 trial indicate that the mpox vaccine MVA-VN has an immune response in adolescents similar to ...

The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is ...

A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.

The study found that vaccination reduced mpox cases by 84% in this population, providing a significant level of protection ...